UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 67

Sortiert nach

Natriuretic peptides and therapeutic applications

Heart failure reviews, 2007-06, Vol.12 (2), p.131-142, Article 131

2007

Volltextzugriff (PDF)

Beneficial Effects of Reconstituted High-Density Lipoprotein (rHDL) on Circulating CD34+ Cells in Patients after an Acute Coronary Syndrome

PloS one, 2017-01, Vol.12 (1), p.e0168448-e0168448

2017

Volltextzugriff (PDF)

Pharmacodynamics of a Novel Designer Natriuretic Peptide, CD-NP, in a First-in-Human Clinical Trial in Healthy Subjects

Journal of clinical pharmacology, 2009-06, Vol.49 (6), p.668-673

2009

Volltextzugriff (PDF)

A pilot study of paternal drug exposure: The Motherisk experience

Reproductive toxicology (Elmsford, N.Y.), 2010-06, Vol.29 (3), p.353-360

2010

Volltextzugriff (PDF)

A Human Study to Evaluate Safety, Tolerability, and Cyclic GMP Activating Properties of Cenderitide in Subjects With Stable Chronic Heart Failure

Clinical pharmacology and therapeutics, 2018-09, Vol.104 (3), p.546-552

2018

Volltextzugriff (PDF)

Natriuretic peptides and therapeutic applications

Heart failure reviews, 2007-06, Vol.12 (2), p.131

2007

Volltextzugriff (PDF)

Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing in vivo and ex vivo actions

European heart journal. Cardiovascular pharmacotherapy, 2016-04, Vol.2 (2), p.98-105

2016

Volltextzugriff (PDF)

A novel chimeric natriuretic peptide reduces cardiomyocyte hypertrophy through the NHE-1–calcineurin pathway

Cardiovascular research, 2010-12, Vol.88 (3), p.434-442

2010

Volltextzugriff (PDF)

ApoA-1 infusion reduces arterial cholesterol and myocardial lesions in a rat model of cardiac dysfunction and insulin resistance

Atherosclerosis, 2012-06, Vol.222 (2), p.402-408

2012

Volltextzugriff (PDF)

Digoxin Toxicity Precipitated by Clarithromycin Use: Case Presentation and Concise Review of the Literature

Canadian journal of cardiology, 2011-11, Vol.27 (6), p.870.e15-870.e16

2011

Volltextzugriff (PDF)

Designer Natriuretic Peptides

Journal of investigative medicine, 2009-01, Vol.57 (1), p.18-21

2009

Volltextzugriff (PDF)

CD-NP, A NOVEL PEPTIDE DESIGNED TO ACTIVATE BOTH GUANYLYL CYCLASE B AND A, ACTIVATES THE SECOND MESSENGER CGMP, SUPPRESSES ALDOSTERONE AND PRESERVES GFR WITHOUT REDUCING BLOOD PRESSURE IN A PROOF-OF-CONCEPT STUDY IN PATIENTS WITH CHRONIC HEART FAILURE

Journal of the American College of Cardiology, 2011-04, Vol.57 (14), p.E325-E325

2011

Volltextzugriff (PDF)

Thoracic Endovascular Aortic Repair of an Aberrant Right Subclavian Artery: Technique and Long-Term Outcome

Journal of cardiac surgery, 2010-07, Vol.25 (4), p.390-393

2010

Volltextzugriff (PDF)

Novel Renal Targeted Protein Therapeutics in Experimental Overt Heart Failure and Renal Dysfunction with an Innovative Chimeric Natriuretic Peptide: ABC-NP

Journal of cardiac failure, 2008-08, Vol.14 (6), p.S76-S76

2008

Volltextzugriff (PDF)

Pharmacodynamics Pharmacodynamics of a Novel Designer Natriuretic Peptide, CD-NP, in a First-in-Human Clinical Trial in Healthy Subjects

Journal of clinical pharmacology, 2009-06, Vol.49 (6), p.668-673

2009

Volltextzugriff (PDF)

Beneficial Effects of Reconstituted High-Density Lipoprotein

PloS one, 2017-01, Vol.12 (1), p.e0168448

2017

Volltextzugriff (PDF)

Beneficial Effects of Reconstituted High-Density Lipoprotein on Circulating CD34.sup.+ Cells in Patients after an Acute Coronary Syndrome

PloS one, 2017-01, Vol.12 (1), p.e0168448

2017

Volltextzugriff (PDF)

Designer Natriuretic Peptides

Journal of investigative medicine, 2009-01, Vol.57 (1), p.18-21

2009

Volltextzugriff (PDF)

Abstract 5432: Mutation of Three Amino Acids in the Disulfide-Ring of a CNP Based Chimeric Natriuretic Peptide Alters its Vascular Properties

Circulation (New York, N.Y.), 2008-10, Vol.118 (suppl_18)

2008

Volltextzugriff (PDF)

Abstract 2495: Pharmacodynamic Profile of a Novel Chimeric Natriuretic Peptide, CD-NP, as Compared to C-Type Natriuretic Peptide

Circulation (New York, N.Y.), 2007-10, Vol.116 (suppl_16)

2007

Volltextzugriff (PDF)

Unusual reactions to 5-HT3 receptor antagonists in a child with rhabdomyosarcoma

Canadian Journal of Clinical Pharmacology (Online), 2010, Vol.17 (1), p.e1-e4

2010

Volltextzugriff (PDF)

Cenderitide (CD-NP), a novel peptide designed to activate both guanylyl cyclase B and A, activates the second messenger cGMP, suppresses aldosterone, and preserves GFR without reducing blood pressure in a proof-of-concept study in patients with chronic heart failure

BMC pharmacology, 2011-08, Vol.11 (S1), p.P18-P18, Article P18

2011

Volltextzugriff (PDF)

Evaluation of a novel sodium -calcium exchange inhibitor, SEA0400, in the JCR:LA-cp rat, a model of the metabolic syndrome and cardiovascular disease

Lee, Candace Y. W

2005

Volltextzugriff (PDF)

Pharmacokinetic and pharmacodynamic study of a novel chimeric natriuretic peptide, CD-NP, in the normal dog

BMC pharmacology, 2007-07, Vol.7 (S1), p.P38-P38, Article P38

2007

Volltextzugriff (PDF)

ANP, BNP and CNP: Physiology and Pharmacology of the Cardiorenal Axis

Textbook of Nephro-Endocrinology, 2008, p.287-307

2008

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(52)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(48)
Life Sciences & Biomedicine
(44)
Humans
(40)
Male
(30)
Female
(26)
Middle Aged
(18)
Aged
(14)
Biological And Medical Sciences
(12)
Adult
(10)
Medical Sciences
(10)
Risk Factors
(9)
Treatment Outcome
(8)
Animals
(7)
Cardiac & Cardiovascular Systems
(7)
Cardiovascular System & Cardiology
(7)
Diabetes
(7)
Diabetes Mellitus, Type 2 - Complications
(6)
General & Internal Medicine
(6)
Medicine, General & Internal
(6)
Obesity - Complications
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Natriuretic peptides and therapeutic applications

Beneficial Effects of Reconstituted High-Density Lipoprotein (rHDL) on Circulating CD34+ Cells in Patients after an Acute Coronary Syndrome

Pharmacodynamics of a Novel Designer Natriuretic Peptide, CD-NP, in a First-in-Human Clinical Trial in Healthy Subjects

A pilot study of paternal drug exposure: The Motherisk experience

A Human Study to Evaluate Safety, Tolerability, and Cyclic GMP Activating Properties of Cenderitide in Subjects With Stable Chronic Heart Failure

Natriuretic peptides and therapeutic applications

Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing in vivo and ex vivo actions

A novel chimeric natriuretic peptide reduces cardiomyocyte hypertrophy through the NHE-1–calcineurin pathway

ApoA-1 infusion reduces arterial cholesterol and myocardial lesions in a rat model of cardiac dysfunction and insulin resistance

Digoxin Toxicity Precipitated by Clarithromycin Use: Case Presentation and Concise Review of the Literature

Designer Natriuretic Peptides

CD-NP, A NOVEL PEPTIDE DESIGNED TO ACTIVATE BOTH GUANYLYL CYCLASE B AND A, ACTIVATES THE SECOND MESSENGER CGMP, SUPPRESSES ALDOSTERONE AND PRESERVES GFR WITHOUT REDUCING BLOOD PRESSURE IN A PROOF-OF-CONCEPT STUDY IN PATIENTS WITH CHRONIC HEART FAILURE

Thoracic Endovascular Aortic Repair of an Aberrant Right Subclavian Artery: Technique and Long-Term Outcome

Novel Renal Targeted Protein Therapeutics in Experimental Overt Heart Failure and Renal Dysfunction with an Innovative Chimeric Natriuretic Peptide: ABC-NP

Pharmacodynamics Pharmacodynamics of a Novel Designer Natriuretic Peptide, CD-NP, in a First-in-Human Clinical Trial in Healthy Subjects

Beneficial Effects of Reconstituted High-Density Lipoprotein

Beneficial Effects of Reconstituted High-Density Lipoprotein on Circulating CD34.sup.+ Cells in Patients after an Acute Coronary Syndrome

Designer Natriuretic Peptides

Abstract 5432: Mutation of Three Amino Acids in the Disulfide-Ring of a CNP Based Chimeric Natriuretic Peptide Alters its Vascular Properties

Abstract 2495: Pharmacodynamic Profile of a Novel Chimeric Natriuretic Peptide, CD-NP, as Compared to C-Type Natriuretic Peptide

Unusual reactions to 5-HT3 receptor antagonists in a child with rhabdomyosarcoma

Cenderitide (CD-NP), a novel peptide designed to activate both guanylyl cyclase B and A, activates the second messenger cGMP, suppresses aldosterone, and preserves GFR without reducing blood pressure in a proof-of-concept study in patients with chronic heart failure

Evaluation of a novel sodium -calcium exchange inhibitor, SEA0400, in the JCR:LA-cp rat, a model of the metabolic syndrome and cardiovascular disease

Pharmacokinetic and pharmacodynamic study of a novel chimeric natriuretic peptide, CD-NP, in the normal dog

ANP, BNP and CNP: Physiology and Pharmacology of the Cardiorenal Axis

Suchergebnisse filtern